Dr. Antony Rosen on the Scleroderma Research Foundation Program

Recent Posts

• Stem cell transplant safely eases scleroderma symptoms for teen
• New study flags existing medications as possible scleroderma treatments
• Anti-CD146 antibodies may signal occupational exposure in SSc: Study
• New SSc drug safely cuts Raynaud’s attack duration, eases symptoms
• Carbon dioxide hand baths may help in SSc-related Raynaud’s, study finds
• More SSc-ILD patients receive early treatment, new study finds
• CD13 levels elevated in scleroderma, but biomarker value unclear
• New lab findings support development of stem cell treatments for SSc-ILD
• Type of immune cell may be key driver of scleroderma scarring: Study
• Abnormal fatty acid metabolism may play role in scleroderma: Analysis